Compound, pharmaceutical composition thereof and use thereof as an IDH1 mutation inhibitor for cancer treatment

摘要

Provided are compounds of formula (I), wherein X, Y, Z, W, V, R2, R3 and m are defined as in the description. Their pharmaceutical compositions and their uses for treating cancers are also provided.